Akums Drugs and Pharmaceuticals Limited — Updates, 14-05-2026: General Updates

Akums Drugs' board approved Q4/FY26 financial results and proposed a total dividend of Rs 3.00/share. 4.81 Cr IPO funds were reallocated for acquisitions and general corporate purposes. An ongoing Income Tax search has an unascertainable financial impact. A new HR President was appointed.